Bausch + Lomb Bi-Blade+ Boosts Retina Surgery Efficiency
VAUGHAN, Ontario, May 7, 2026 Bausch + Lomb announced the European launch of its advanced Bi-Blade+™ dual-port vitrectomy cutter...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease solid tumors targeted therapy
VAUGHAN, Ontario, May 7, 2026 Bausch + Lomb announced the European launch of its advanced Bi-Blade+™ dual-port vitrectomy cutter...
DRAPER, Utah, May 4, 2026 Ortho Development Corporation (ODEV) has announced the full commercial launch of the Trivicta® Hip...
WESTBOROUGH, MASSACHUSETTS, April 28, 2026 Olympus Corporation has received FDA 510(k) clearance for its latest innovation, the POWERSEAL™ Open...
BESANÇON, France, March 24, 2026 Pixee Medical has announced the U.S. launch of its Knee+ NexSight augmented reality (AR)...
ATLANTA, Feb. 23, 2026 — MiRus announced U.S. FDA 510(k) clearance and commercial launch of the IO™ Expandable Wedge...
Paris and Tampa, Fla., Jan. 13, 2026 — SafeHeal®, a clinical-stage medical device innovator in colorectal surgery, announced the...
RAHWAY, N.J. — December 3, 2025 — Mexico’s Secretariat of Agriculture and Rural Development (SADER) has granted approval for...
Minneapolis, MN — December 3, 2025 — Medtronic announced that the U.S. Food and Drug Administration (FDA) has granted...
